Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Jun
11
2018
Ride-Sharing Services Lose Latest Trade Secret Battle Foley & Lardner LLP
Jul
1
2018
New Types of Section 337 Investigations at the International Trade Commission Foley & Lardner LLP
Jul
17
2018
Ranging Beyond The Written Description Requirement Foley & Lardner LLP
Aug
30
2018
USPTO Offers Refund of Certain Non-Electronic Filing Fees Incurred During DSUEBSO Foley & Lardner LLP
May
16
2023
Software as a Medical Device: Challenges Facing the Industry Foley & Lardner LLP
Jan
7
2019
USPTO Issues Revised Patent Subject Matter Eligibility Guidance Foley & Lardner LLP
Jul
8
2023
Full Federal Circuit Set to Consider Changing the Test for Obviousness of Design Patents Foley & Lardner LLP
Aug
15
2023
Positioning for the Exit at the Entrance Foley & Lardner LLP
Mar
14
2019
IP Considerations for Autonomous Vehicle Technology Startups and Automotive Suppliers Foley & Lardner LLP
Apr
3
2019
Right Tool, Right Job: Smart Manufacturing Requires Focus on Intellectual Property Foley & Lardner LLP
Nov
15
2023
USPTO Director Uses New Review Process to Order Independent Rehearing of PTAB Institution Decision Foley & Lardner LLP
Jun
25
2019
Federal Circuit Agrees “Pharmaceutical Composition” May Be Toxic Foley & Lardner LLP
Dec
11
2023
Startup Advisors: What Sources of Financing are Available to Startups? [VIDEO] Foley & Lardner LLP
Jul
9
2019
Automotive Market Intelligence Foley & Lardner LLP
Dec
20
2023
Startup Advisors: How to Prepare for a Financing [VIDEO] Foley & Lardner LLP
Oct
1
2019
PTAB Precedential 35 U.S.C. 315(b) Decisions Show Service in Dismissed Infringement Cases Can Still Bar IPR Institution Foley & Lardner LLP
Nov
13
2019
USPTO Updates Guidance on Patent-Eligibility of Personalized Therapy Foley & Lardner LLP
Jun
7
2016
PTAB Institutes Post Grant Review Against Chemical Process Patent Foley & Lardner LLP
Jul
14
2016
Janssen Seeks Injunction Against Remicade Biosimilar Based On Cell Culture Patent Foley & Lardner LLP
Mar
24
2020
Federal Circuit Finds Eligibility In Non-Diagnostic Method Foley & Lardner LLP
Aug
23
2016
Federal Circuit Affirms Tygacil Formulation Patent Foley & Lardner LLP
Oct
5
2016
Sovereign Immunity of State Universities: Can It Shield Them from AIA Patent Challenges? Foley & Lardner LLP
Nov
8
2016
USPTO Examination Time Goals -- How Much Time Should Examiners Have To Examine Patent Application? Foley & Lardner LLP
Jul
6
2020
USPTO Offers New Fast Track Appeals Pilot Program Foley & Lardner LLP
Apr
11
2017
PTAB Not Bound By Prior Court Decisions Upholding Exelon Patents Foley & Lardner LLP
Apr
25
2017
No Nexus For Novartis Gilenya Patent Foley & Lardner LLP
May
16
2017
USPTO Patent Term Adjustment Error Costs Patent Owners Time And Money Foley & Lardner LLP
Feb
25
2021
Arthrex’s Reply – Removing Tenure Doesn’t Solve the Problem and Defies Congressional Intent Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins